WB
www.bivisionpharma.com
The company develops targeted radiopharmaceuticals using a proprietary technology platform that selects specific targeting ligands and radiation drug-conjugates for clinical applications. This approach aims to provide effective treatment options for patients with significant unmet medical needs in oncology.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The company develops targeted radiopharmaceuticals using a proprietary technology platform that selects specific targeting ligands and radiation drug-conjugates for clinical applications. This approach aims to provide effective treatment options for patients with significant unmet medical needs in oncology.